Literature DB >> 1498059

Biology and treatment of gliomas.

T J Janus1, A P Kyritsis, A D Forman, V A Levin.   

Abstract

This review discusses some of the recent advances in glioma research and treatment. Our understanding of the characteristics of these tumors has been strengthened by the application of molecular biologic and genetic techniques to pathologic grading and therapy outcome. Newer attempts to correlate imaging modalities to pathologic grading are also discussed. It is anticipated that these developments will strengthen our ability to design improved treatment strategies, an essential goal inasmuch as current treatment schemes have limited benefit. More work needs to be done to understand the biology of these tumors especially the complex interactions of their cytokine expression, multiplicity of genetic abnormalities, and their local environment. Only then will be able to develop improved therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1498059     DOI: 10.1093/oxfordjournals.annonc.a058228

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  5 in total

1.  Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes.

Authors:  S Tanaka; H Kamitani; M R Amin; T Watanabe; H Oka; K Fujii; T Nagashima; T Hori
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

2.  Clinical development of experimental therapies for malignant glioma.

Authors:  Nikolai G Rainov; Volkmar Heidecke
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

3.  Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines.

Authors:  J I Garrison; M E Berens; J R Shapiro; S Treasurywala; G Floyd-Smith
Journal:  J Neurooncol       Date:  1996-12       Impact factor: 4.130

Review 4.  High dose chemotherapy for the treatment of malignant brain tumors.

Authors:  S H Petersdorf; R B Livingston
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.

Authors:  C Urban; M Benesch; B Pakisch; H Lackner; R Kerbl; W Schwinger; R Oberbauer
Journal:  J Neurooncol       Date:  1998-08       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.